How have BSTG shares performed in 2024?

Biostage's stock was trading at $4.45 at the start of the year. Since then, BSTG shares have increased by 0.0% and is now trading at $4.45. View the best growth stocks for 2024 here .

How were Biostage's earnings last quarter?

Biostage, Inc. (OTCMKTS:BSTG) announced its quarterly earnings results on Thursday, August, 13th. The company reported ($0.14) earnings per share for the quarter.

What other stocks do shareholders of Biostage own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Biostage investors own include Fulcrum Therapeutics (FULC) , Allena Pharmaceuticals (ALNA) , VIVUS (VVUS) , Aldeyra Therapeutics (ALDX) , Arbutus Biopharma (ABUS) , Akero Therapeutics (AKRO) , Ampliphi Biosciences (APHB) , Ardelyx (ARDX) , Armata Pharmaceuticals (ARMP) and Athersys (ATHX) .

How do I buy shares of Biostage?

Shares of BSTG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:BSTG

Biostage (BSTG) Stock Price, News & Analysis

→ A.I. “Perfect Storm” Could Send THESE Stocks Sky High (From InvestorPlace) (Ad)

Free BSTG Stock Alerts

$4.45

0.00 (0.00%)

(As of 07/24/2023)

Compare

Today's Range: $4.45
▼
$4.45
50-Day Range: $4.45
▼
$4.45
52-Week Range: $4.45
▼
$4.45

Volume: N/A
Average Volume: 1,847 shs
Market Capitalization: $61.77 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Earnings

Get Biostage alerts:

Ad InvestorPlace

A.I. “Perfect Storm” Could Send THESE Stocks Sky High

A little-known investment analyst whose performance beat out 15,000+ other experts in 2020 has identified an opportunity in the A.I. space. He's calling it A.I.'s perfect storm.

>>Check out what this A.I. Perfect Storm is<<

About Biostage Stock (OTCMKTS:BSTG)

Biostage, Inc., a biotechnology company, offers products to cure patients of cancers, injuries, and birth defects of the gastro-intestinal tract and the airways. The company's pipeline includes organ-regeneration technology for the repair or replacement of diseased or damaged organs, as well as product candidates to treat cancer, injury, and birth defects of the bronchus. Its lead product candidate is Biostage Esophageal Implant for the treatment of severe esophageal disease. The company was formerly known as Harvard Apparatus Regenerative Technology, Inc. and changed its name to Biostage, Inc. in March 2016. Biostage, Inc. was founded in 2009 and is headquartered in Holliston, Massachusetts.

BSTG Stock Price History

30 days | 90 days | 365 days | Advanced Chart

BSTG Stock News Headlines

January 5, 2024 | investing.com

Harvard Apparatus Regenerative Technology Inc (HRGN)

August 22, 2023 | seekingalpha.com

HRGN Harvard Apparatus Regenerative Technology Inc.

April 16, 2024 | Paradigm Press (Ad)

Bitcoin Rockets To Record High But Buy THIS Instead

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

July 20, 2023 | finance.yahoo.com

Biostage, Inc. Changes Name to Harvard Apparatus Regenerative Technology, Inc. (OTCQB: HRGN)

July 18, 2023 | finance.yahoo.com

Biostage Activated Mayo Clinic as The First Site for Clinical Trial in Severe Esophageal Disease

July 11, 2023 | benzinga.com

Biostage CEO Awarded $1.07M Worth of Stock Options

June 13, 2023 | finance.yahoo.com

Biostage to Host Investor Call

May 31, 2023 | finance.yahoo.com

Biostage Initiated Study Start-up Activities for Clinical Trial in Severe Esophageal Disease

April 16, 2024 | Paradigm Press (Ad)

Bitcoin Rockets To Record High But Buy THIS Instead

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

May 16, 2023 | benzinga.com

Biostage Stock (OTC:BSTG), Insider Trading Activity

April 24, 2023 | sg.finance.yahoo.com

Biostage, Inc. (BSTG) stock historical prices & data – Yahoo Finance

April 23, 2023 | ca.finance.yahoo.com

Biostage, Inc. (BSTG) Stock Historical Prices & Data - Yahoo Finance

April 10, 2023 | finance.yahoo.com

Biostage Appoints Ron Packard to Board of Directors

April 6, 2023 | finance.yahoo.com

Biostage Announces $6 Million Financing to Advance Clinical Trial

March 2, 2023 | finance.yahoo.com

Biostage Announces Chairman and CEO Transition

February 3, 2023 | msn.com

Regenerative medicine developer Biostage cancels Nasdaq uplisting, public offering

January 12, 2023 | finance.yahoo.com

Biostage Amends CEO Employment Agreement

December 28, 2022 | finance.yahoo.com

Biostage, Inc. (OTC:BSTG) Q3 2022 Earnings Call Transcript

December 28, 2022 | prnewswire.com

Biostage Selects IQVIA to Manage its FDA-Approved Clinical Trial in Severe Esophageal Disease, including Cancer

December 23, 2022 | finance.yahoo.com

New Publication Demonstrates Rapid Esophageal Regeneration using the Biostage Esophageal Implant

November 15, 2022 | seekingalpha.com

Biostage, Inc. (BSTG) Q3 2022 Earnings Call Transcript

November 15, 2022 | finance.yahoo.com

Biostage Reports Corporate Highlights and Third Quarter Financial Results

November 10, 2022 | finance.yahoo.com

Biostage Schedules Conference Call and Webcast for Q3 2022 Results

October 29, 2022 | seekingalpha.com

Regenerative therapy developer Biostage files for Nasdaq uplisting, $6M offering

October 25, 2022 | finance.yahoo.com

Biostage Receives U.S. Patent for Cellularized Patch-Based Scaffolds for Organ Repair

August 8, 2022 | finance.yahoo.com

Biostage Announces Appointment of New Chief Financial Officer

August 4, 2022 | finance.yahoo.com

Biostage Reports Corporate Highlights and Second Quarter Financial Results

See More Headlines

Receive BSTG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Biostage and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 8/13/2020
Today: 4/15/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Medical
Industry: Surgical & medical instruments
Sub-Industry: N/A
Current Symbol: OTCMKTS:BSTG
CUSIP: N/A
CIK: 1563665
Web: www.biostage.com
Phone: (744) 233-7300
Fax: 774-233-7302
Employees: 7
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): ($0.58)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-6,070,000.00
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: -174.43%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 2.73
Quick Ratio: 2.73

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: ($0.26) per share
Price / Book: -17.12

Miscellaneous

Outstanding Shares: 13,882,000
Free Float: 11,758,000
Market Cap: $61.77 million
Optionable: Not Optionable
Beta: -1.02

5G Stocks: The Path Forward is Profitable

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Key Executives

Mr. Junli He (Age 49)
CEO & Chairman
Mr. Yu Hong (Age 50)
Pres
Comp: $158.06k
Dr. William L. Fodor Ph.D. (Age 64)
Chief Scientific Officer
Comp: $207.85k
Mr. Joseph L. Damasio Jr. (Age 49)
Chief Financial Officer
Dr. Shunfu Hu Ph.D.
VP of Bus. Devel. & Operations

Key Competitors

View All Competitors

BSTG Stock Analysis - Frequently Asked Questions

How have BSTG shares performed in 2024?: Biostage's stock was trading at $4.45 at the start of the year. Since then, BSTG shares have increased by 0.0% and is now trading at $4.45.
View the best growth stocks for 2024 here.
How were Biostage's earnings last quarter?: Biostage, Inc. (OTCMKTS:BSTG) announced its quarterly earnings results on Thursday, August, 13th. The company reported ($0.14) earnings per share for the quarter.
What other stocks do shareholders of Biostage own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Biostage investors own include Fulcrum Therapeutics (FULC), Allena Pharmaceuticals (ALNA), VIVUS (VVUS), Aldeyra Therapeutics (ALDX), Arbutus Biopharma (ABUS), Akero Therapeutics (AKRO), Ampliphi Biosciences (APHB), Ardelyx (ARDX), Armata Pharmaceuticals (ARMP) and Athersys (ATHX).
How do I buy shares of Biostage?: Shares of BSTG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:BSTG) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial